^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

BCMA-targeted antibody-drug conjugate

Phase 2
Emory University
Recruiting
Last update posted :
08/12/2024
Initiation :
07/21/2022
Primary completion :
10/21/2025
Completion :
10/21/2026
CD4
|
Chr t(4;14) • Chr t(14;16)
|
pomalidomide • Blenrep (belantamab mafodotin-blmf) • Hemady (dexamethasone tablets)
Phase 3
GlaxoSmithKline
Active, not recruiting
Last update posted :
06/10/2024
Initiation :
04/02/2020
Primary completion :
09/12/2022
Completion :
06/26/2025
CD4
|
dexamethasone • pomalidomide • Blenrep (belantamab mafodotin-blmf)
Phase 1
M.D. Anderson Cancer Center
Recruiting
Last update posted :
05/08/2024
Initiation :
01/05/2023
Primary completion :
05/01/2025
Completion :
05/01/2025
CD4
|
Blenrep (belantamab mafodotin-blmf)
Phase 1
Memorial Sloan Kettering Cancer Center
Recruiting
Last update posted :
05/07/2024
Initiation :
10/04/2022
Primary completion :
10/01/2026
Completion :
10/01/2026
SDC1
|
pomalidomide • Blenrep (belantamab mafodotin-blmf) • Ogsiveo (nirogacestat)
Phase 2
Cristiana Costa Chase, DO
Not yet recruiting
Last update posted :
04/22/2024
Initiation :
06/01/2024
Primary completion :
09/01/2025
Completion :
09/01/2027
CD4
|
Blenrep (belantamab mafodotin-blmf)
Phase 1
GlaxoSmithKline
Completed
Last update posted :
04/19/2024
Initiation :
12/09/2019
Primary completion :
12/30/2022
Completion :
12/30/2022
CD8
|
CD38 positive
|
Blenrep (belantamab mafodotin-blmf)
Phase 1/2
Hellenic Society of Hematology
Recruiting
Last update posted :
12/01/2023
Initiation :
04/13/2022
Primary completion :
03/15/2026
Completion :
03/15/2026
CD4
|
lenalidomide • Darzalex (daratumumab) • dexamethasone • Blenrep (belantamab mafodotin-blmf)
Phase 1/2
Hellenic Society of Hematology
Active, not recruiting
Last update posted :
10/24/2023
Initiation :
02/22/2021
Primary completion :
09/08/2028
Completion :
11/08/2028
CD4
|
lenalidomide • dexamethasone • Blenrep (belantamab mafodotin-blmf) • dexamethasone injection
Phase 1/2
Hellenic Society of Hematology
Recruiting
Last update posted :
10/24/2023
Initiation :
07/14/2023
Primary completion :
10/31/2026
Completion :
10/31/2026
CD4
|
lenalidomide • dexamethasone • Blenrep (belantamab mafodotin-blmf) • Ogsiveo (nirogacestat)
Phase 1/2
Hellenic Society of Hematology
Not yet recruiting
Last update posted :
10/17/2022
Initiation :
10/20/2022
Primary completion :
10/31/2026
Completion :
10/31/2026
CD4
|
lenalidomide • Darzalex (daratumumab) • dexamethasone • pomalidomide • Blenrep (belantamab mafodotin-blmf)
Phase 2
PETHEMA Foundation
Recruiting
Last update posted :
12/06/2021
Initiation :
04/07/2021
Primary completion :
03/01/2025
Completion :
07/01/2025
CD34
|
lenalidomide • bortezomib • dexamethasone • melphalan • Blenrep (belantamab mafodotin-blmf)